Alzheimer's disease. Arresting memory decline.
Robbins
T W
TW
D000544:Alzheimer Disease / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D000818:Animals; D002243:Carbolines / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D006801:Humans; D008569:Memory Disorders / Q000188:drug therapy* / Q000209:etiology; D009538:Nicotine / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D051381:Rats; D011950:Receptors, Cholinergic / Q000187:drug effects / Q000502:physiology; D011963:Receptors, GABA-A / Q000187:drug effects / Q000502:physiology; D011978:Receptors, Nicotinic / Q000502:physiology; D013844:Thiazoles / Q000627:therapeutic use
D002243:Carbolines; D002800:Cholinesterase Inhibitors; D010880:Piperidines; D011950:Receptors, Cholinergic; D011963:Receptors, GABA-A; D011978:Receptors, Nicotinic; D013844:Thiazoles; D009538:Nicotine; C055163:sabeluzole